1. Resmetirom. Thyroid hormone receptor-beta agonist, Treatment of nonalcoholic steatohepatitis;Drugs of the Future;2020
2. Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia;Journal of Medicinal Chemistry;2014-04-08
3. Discovery of pyrrolopyridazines as novel DGAT1 inhibitors;Bioorganic & Medicinal Chemistry Letters;2010-10
4. References;Handbook of Heterocyclic Chemistry;2010
5. References;Chemistry of Heterocyclic Compounds: A Series Of Monographs;2008-01-02